71
Pulmonary Function Testing Dr. Alireza Safaiyan Occupational medicine specialist

Dr. Alireza Safaiyan Occupational medicine specialist

Embed Size (px)

Citation preview

  • Slide 1
  • Dr. Alireza Safaiyan Occupational medicine specialist
  • Slide 2
  • PFT Pulmonary Function Testing PFTs can include : 1) Simple screening spirometry 2) Formal lung volume measurement 3) Diffusing capacity for carbon monoxide 4) Arterial blood gases 5) Inhalation challenge tests 6) Exercise stress tests
  • Slide 3
  • Total lung capacity (TLC) FRC is usually measured by: 1) gas dilution technique or 2) body plethysmography
  • Slide 4
  • Gas dilution technique Helium dilution techniques: based on the inhalation of a known concentration and volume of an inert tracer gas, such as helium, followed by equilibration of 7 to 10 minutes in the closed- circuit helium dilution technique. The final exhaled helium concentration is diluted in proportion to the unknown volume of air in the patient's chest (residual volume). Nitrogen-washout technique: the patient breathes 100% oxygen, and all the nitrogen in the lungs is washed out. The exhaled volume and the nitrogen concentration in that volume are measured. The difference in nitrogen volume at the initial concentration and at the final exhaled concentration allows a calculation of intrathoracic volume, usually FRC.
  • Slide 5
  • Gas dilution technique A limitation of this technique is that it does not measure air in noncommunicating bullae, and therefore it can underestimate total lung capacity, especially in patients with severe emphysema.
  • Slide 6
  • Body plethysmography principle of Boyle's law, which states that the volume of gas at a constant temperature varies inversely with the pressure applied to it can measure the total volume of air in the chest, including gas trapped in bullae. can be performed quickly
  • Slide 7
  • D L CO Diffusing capacity of the lung for carbon monoxide the single-breath breath-holding technique a subject inhales a known volume of test gas that usually contains 10% helium, 0.3% carbon monoxide, 21% oxygen, and the remainder nitrogen. holds his or her breath for 10 seconds. exhales to wash out a conservative overestimate of mechanical and anatomic dead space. an alveolar sample is collected. D L CO is calculated from the total volume of the lung, breath-hold time, and the initial and final alveolar concentrations of carbon monoxide Hemoglobin concentration is a very important measurement in interpreting reductions in D L CO
  • Slide 8
  • Obstructive Lung Diseases Cystic fibrosis Emphysema Parenchymal Lung Disease Drug reactions (e.g., amiodarone, bleomycin) Idiopathic Interstitial lung disease Lung disease caused by fibrogenic dusts (e.g., asbestosis) Lung disease caused by biologic dusts (e.g., allergic alveolitis) Sarcoidosis Pulmonary Involvement in Systemic Diseases Dermatomyositis-polymyositis Inflammatory bowel disease Mixed connective tissue disease Progressive systemic sclerosis Rheumatoid arthritis Systemic lupus erythematosus Wegener's granulomatosis Cardiovascular Diseases Acute and recurrent pulmonary thromboembolism Acute myocardial infarction Fat embolization Mitral stenosis Primary pulmonary hypertension Pulmonary edema Other Acute and chronic ethanol ingestion Bronchiolitis obliterans with organizing pneumonia (BOOP) Chronic hemodialysis Chronic renal failure Ciagarette smoking Cocaine freebasing Diseases associated with anemia Marijuana smoking Increases In DLCO Diseases associated with increased pulmonary blood flow (e.g., left-to-right intracardiac shunts) Diseases associated with polycythemia Exercise Pulmonary hemorrhage
  • Slide 9
  • Exhaled Nitric Oxide The measurement of exhaled nitric oxide as a reflection of airway inflammation is gaining rapid acceptance as a pulmonary function test
  • Slide 10
  • Inhalation challenge tests (Bronchoprovocation) To define nonspecific airway hyperreactivity Methacholine and histamine are the agents most often used with this procedure inhaled through a nebulizer, although other agents may also be useful. a five-stage procedure with five different increasing concentrations.(0.0625 16 mg/ml) After each stage, the patient performs a spirometry. a 20% reduction in the FEV 1 (PC 20FEV1 ) is significant. In rare cases, a bronchospasm can occur with inhalation challenge testing.
  • Slide 11
  • Exercise stress tests Exercise stress tests evaluate the effect of exercise on lung function tests. Spirometry readings are done after exercise and then again at rest.lung function tests Six-minute walk test
  • Slide 12
  • Slide 13
  • Definition of spirometry A physiological test for measuring volumes inhaled or exhaled by an individual as a function of time A physiological test for measuring volumes inhaled or exhaled by an individual as a function of time A non-invasive method of evaluation of pulmonary function A non-invasive method of evaluation of pulmonary function Not for definitive diagnosis Not for definitive diagnosis Simple, cost effectiveness, accessible Simple, cost effectiveness, accessible Needs patient cooperation Needs patient cooperation
  • Slide 14
  • Indication Not a screening test for general population Not a screening test for general population Diagnostic Diagnostic Monitoring Monitoring Impairment evaluation Impairment evaluation Public health Public health
  • Slide 15
  • Diagnostic To evaluate symptoms Chest pain Cough Dyspnea Orthopnea Phlegm production To evaluate signs Wheezing Chest deformity Cyanosis Diminished breath sounds Expiratory slowing Overinflation Unexplained crackles To evaluate abnormal laboratory tests Abnormal chest radiographs Hypercapnia Hypoxemia Polycythemia To measure the effect of disease on pulmonary function To screen persons at risk for pulmonary diseases Smokers Persons in occupations with exposures to injurious substances Some routine physical examinations To assess preoperative risk To assess prognosis (lung transplant, etc.) To assess health status before enrollment in strenuous physical activity programs
  • Slide 16
  • Monitoring To assess therapeutic interventions Bronchodilator therapy Steroid treatment for asthma, interstitial lung disease, etc. Management of congestive heart failure Other (antibiotics in cystic fibrosis, etc.) To describe the course of diseases affecting lung function Pulmonary diseases Obstructive small airway diseases Interstitial lung diseases Cardiac diseases Congestive heart failure Neuromuscular diseases Guillain-Barr syndrome To monitor persons in occupations with exposure to injurious agents To monitor for adverse reactions to drugs with known pulmonary toxicity
  • Slide 17
  • Evaluation of Disability or Impairment To assess patients as part of a rehabilitation program Medical Industrial Vocational To assess risks as part of an insurance evaluation To assess persons for legal reasons Social Security or other government compensation programs Personal injury lawsuits Other
  • Slide 18
  • Public Health Epidemiologic surveys Comparison of health status of populations living in different environments Validation of subjective complaints in occupational or environmental settings Derivation of reference equations
  • Slide 19
  • Indications in occupational medicine Primary prevention (Pre-employment) Primary prevention (Pre-employment) physical demands of a job require a certain level of cardiopulmonary fitness, eg, heavy manual labor or firefighting Respirator use can impose a significant burden on the cardiopulmonary systems, eg, use of a self-contained breathing apparatus, or prolonged use of certain negative- pressure masks under conditions of heavy physical exertion and/or heat stress Research (Respiratory hazards)
  • Slide 20
  • Secondary prevention Secondary prevention Medical surveillance programs & periodic evaluation Medical surveillance programs & periodic evaluation OSHA : OSHA : asbestos, cadmium, coke oven emissions, or cotton dust asbestos, cadmium, coke oven emissions, or cotton dust respirator-wearers exposed to benzene, formaldehyde methylene chloride respirator-wearers exposed to benzene, formaldehyde methylene chloride Silicosis Silicosis Tertiary prevention Tertiary prevention Follow-up spirometry Follow-up spirometry Workers compensation setting Workers compensation setting
  • Slide 21
  • Contraindications Active hemoptysis Active hemoptysis Pneumothorax Pneumothorax Unstable Cardiovascular status (6 w) Unstable Cardiovascular status (6 w) Cerebral/Thoracic/Abdominal aneurysm Cerebral/Thoracic/Abdominal aneurysm Recent eye surgery Recent eye surgery Acute disorder that may interfere with performance (e.g, vomiting) Acute disorder that may interfere with performance (e.g, vomiting) Thoracic or abdominal surgery( 3 w) Thoracic or abdominal surgery( 3 w) Recent CVA or pulmonary emboli Recent CVA or pulmonary emboli Respiratory distress Respiratory distress
  • Slide 22
  • Confounding factors Common cold (previous 3 days) Common cold (previous 3 days) Severe respiratory infection (previous 3w) Severe respiratory infection (previous 3w) Smoking( 1hr) Smoking( 1hr) Heavy food (1hr) Heavy food (1hr) Bronchodilator use Bronchodilator use
  • Slide 23
  • Complications Chest pain Chest pain Syncope, dizziness Syncope, dizziness Increased ICP Increased ICP Paroxysmal coughing Paroxysmal coughing Nosocomial infection Nosocomial infection Bronchospasm Bronchospasm
  • Slide 24
  • Type of spirometer Flow-type spirometer Volumetric spirometer
  • Slide 25
  • Hygiene & infection control Hand washing Hand washing Gloves Gloves Disposable mouth piece & nose clip Disposable mouth piece & nose clip Disinfection or sterilization of reusable mouth piece Disinfection or sterilization of reusable mouth piece Extra precautions for patient with known transmissible infection Extra precautions for patient with known transmissible infection
  • Slide 26
  • Slide 27
  • Normality and predicted equations lung function, such as FEV 1 or FVC, are affected most significantly by standing height, age, gender, race, and, to a lesser extent, weight These reference standards are based on a cohort of normal subjects of similar age, height, and race, with normal being defined as persons without a history of smoking or disease that can affect lung function.
  • Slide 28
  • Reference values Knudson (male/ female) Knudson (male/ female) National Health and Nutrition Examination Survey (NHANES III) ERS (ECCS) ERS (ECCS) ATS ATS Golshan Golshan ITS ITS
  • Slide 29
  • Spirometric values FVC Forced vital capacity; the total volume of air that can be exhaled during a maximal forced expiration effort. FEV 1 Forced expiratory volume in one second; the volume of air exhaled in the first second under force after a maximal inhalation. FEV 1 / FVC ratioThe percentage of the FVC expired in one second. FEV 6 Forced expiratory volume in six seconds. FEF 2575% Forced expiratory flow over the middle one half of the FVC; the average flow from the point at which 25 percent of the FVC has been exhaled to the point at which 75 percent of the FVC has been exhaled. MVVMaximal voluntary ventilation. This measures the greatest amount of air you can breathe in and out during one minute. Lung volumes ERVExpiratory reserve volume; the maximal volume of air exhaled from end-expiration. IRVInspiratory reserve volume; the maximal volume of air inhaled from end-inspiration. RVResidual volume; the volume of air remaining in the lungs after a maximal exhalation. V T Tidal volume; the volume of air inhaled or exhaled during each respiratory cycle. Lung capacities FRCFunctional residual capacity; the volume of air in the lungs at resting end-expiration. ICInspiratory capacity; the maximal volume of air that can be inhaled from the resting expiratory level. TLCTotal lung capacity; the volume of air in the lungs at maximal inflation. VCVital capacity; the largest volume measured on complete exhalation after full inspiration.
  • Slide 30
  • Spirometry steps Equipment performance criteria Equipment validation Quality control Subject maneuvers Measurements procedures Acceptability Repeatability interpretation
  • Slide 31
  • 4 (1 3 ) 3% 90 (2/91-3/09)
  • Slide 32
  • Subject maneuvers FVC maneuver Closed circuit Closed circuit Open circuit Open circuit Well-fitting false teeth yes or no Well-fitting false teeth yes or no Sitting or standing Nose clip Procedure Procedure 1. Inhale compete 2. Exhale: with minimal hesitation blast not just blow keep going
  • Slide 33
  • maneuver evaluation Start of test criteria Start of test criteria - Extrapolation volume (EV < 5% of FVC or 150 ml) - Time-to-PEF < 0.120 s - Time-to-PEF < 0.120 s End of test criteria End of test criteria - the subject cannot or should not continue - exhalation at least 6s (in children